Locations:
February 15, 2022/Cancer

Let’s Talk About Childhood Cancer Survivorship (Podcast)

Seth Rotz, MD, joins the Cancer Advances podcast to share insights

Pediatric cancer survivor

More children are surviving childhood cancers than ever before. Each year in the United States about 15,000 children are diagnosed with cancer, and about 80% to 85% will survive five years or longer.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

While these numbers are encouraging, pediatric oncologists say a shift to better longer-term management of pediatric cancer survivors is warranted. The Childhood Cancer Survivorship Program at Cleveland Clinic Children’s is focused on doing just that.

Led by pediatric hematologist/oncologist Seth Rotz, MD, the physicians work with pediatric cancer survivors, their families, and other subspecialists as needed to identify risks and monitor late effects associated with disease and its treatment. They also provide counsel and resources related to other concerns, such as family planning and psychosocial issues.

Dr. Rotz joined the Cancer Advances podcast to discuss the goals of the program, the biggest issues in childhood cancer survivorship programs, and the next exciting thing in the field.

An excerpt from the podcast

“Our focus in cancer survivorship has focused a great deal on the medical effects of having received chemotherapy and radiation. And, I think, in the last several years, there’s just been more attention focused on questions like: What are the long-term psychological impacts? What are the financial impacts of having had cancer? Does this impact whether a teenager ends up applying to college or not? Or does it put somebody in a position where they can’t change jobs because they’re worried about health insurance coverage and so forth,” he says.

“And then we have so many people and parents, too, who have some degree of post-traumatic stress from their treatment, and so we are trying to identify different mental health issues that can go along with treatment and get people plugged in with the resources they need, which is another very important part of what we do.”

Advertisement

Featured in Cleveland Clinic Children's 2022 Year in Review

Advertisement

Related Articles

Bispecific antibodies
September 11, 2026/Cancer/Innovations

Bispecific Antibodies May Change the Face of AL Amyloidosis

Practice changes needed to expand access across academic and community settings

T-cell
September 9, 2026/Cancer/Innovations

Patient Case Study: CAR-T Cell Therapy Leads to Complete Remission for Relapsed AL Amyloidosis

Treatment yields positive results despite late diagnosis and cardiac involvement

Patient with physician
September 3, 2026/Cancer/Patient Support

Guiding Patients through Cancer Screenings

Early detection program integrates multiple disciplines to reduce screening barriers and patient anxiety

Medical illustration of blood cells
August 25, 2026/Cancer/Benign Hematology

Understanding Rebalancing Agents

Newer class of medications evolves care models for patients with hemophilia

Patient greeting physician
August 12, 2026/Cancer/Benign Hematology

Classical Hematology 2.0

Improving access to specialists

Large meningiolma
August 6, 2026/Cancer/Brain Tumor

Case Study: Patient with Large Meningioma Thriving After Treatment

Dotatate PET/CT scan and molecular testing informed treatment trajectory

Young couple cooking
July 27, 2026/Cancer/Patient Support

Empowering Cancer Survivors through Lifestyle Medicine

A proactive, framework-based approach

Physician checking patient's heart rate
July 15, 2026/Cancer

First-Generation BTK Inhibitors Associated with Higher Risk of Cardiac Events

Patients on ibrutinib were more than twice as likely to experience atrial fibrillation or heart failure than those on second-generation alternatives.

Ad